Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO.
The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in 2006. The company is based in Salt Lake City, Utah.
Funding Rounds (3) - $41.53MUpdate
Current Team (4)Update
Board Members and Advisors (2)Update
|Sep 16, 2016||jnj.com - Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.|
|Dec 21, 2015||PRNewswire UK All - Left Atrial Appendage (LAA) Closure Market to Grow at 28% CAGR to 2020|
|Dec 7, 2015||PRWeb Sitemap - CoNextions Medical CEO Richard J. Linder is Honored by BioUtah with Outstanding Entrepreneurial Spirit Award|
|Nov 20, 2015||Bio Portfolio - Outcome Capital Announces Biosense Webster, Inc. Has Acquired Coherex Medical|
|Oct 12, 2009||OnBioVC - Coherex Medical, Inc.: Series B $16.5MbyOnBioVC|
|Apr 19, 2007||PE HUB - PE HUB|
3598 West 1820 South
Salt Lake City, UT 84104